CK2—An Emerging Target for Neurological and Psychiatric Disorders

Author： Castello Julia   Ragnauth Andre   Friedman Eitan   Rebholz Heike  

Publisher： MDPI

E-ISSN： 1424-8247|10|1|7-7

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.10, Iss.1, 2017-01, pp. : 7-7

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Updated View on an Emerging Target: Selected Papers from the 8th International Conference on Protein Kinase CK2

By Jose Joachim   Le-Borgne Marc   Pinna Lorenzo A.   Montenarh Mathias  

Pharmaceuticals, Vol. 10, Iss. 2, 2017-03 ,pp. : 33-33

MDPI

Access to resources Recommend Favorite

CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target

By Chua Melissa M.J.   Ortega Charina E.   Sheikh Ayesha   Lee Migi   Abdul-Rassoul Hussein   Hartshorn Kevan L.   Dominguez Isabel  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

An Emerging Role for Long Non-Coding RNA Dysregulation in Neurological Disorders

By Fenoglio Chiara   Ridolfi Elisa   Galimberti Daniela   Scarpini Elio  

International Journal of Molecular Sciences, Vol. 14, Iss. 10, 2013-10 ,pp. : 20427-20442

MDPI

Access to resources Recommend Favorite

Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies

By Tejeda Gonzalo S.   Díaz-Guerra Margarita  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 268-268

MDPI

Access to resources Recommend Favorite

Drosophila Protein Kinase CK2: Genetics, Regulatory Complexity and Emerging Roles during Development

By Bandyopadhyay Mohna   Arbet Scott   Bishop Clifton P.   Bidwai Ashok P.  

Pharmaceuticals, Vol. 10, Iss. 1, 2016-12 ,pp. : 4-4

MDPI

Access to resources Recommend Favorite